Asia Pacific Next Generation Sequencing Market: By Type and Services ), By Technology, Whole Exome Sequencing, De Novo Sequencing, ChiP Sequencing, Methylation Sequencing, and Others), By Application By End User, and Country  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Asia Pacific Next Generation Sequencing (NGS) Market: By Type (Products (Instruments & Software, Consumables (Reagents & kits) and Services (Sequencing Services and Data Analysis Services)), By Technology (Whole Targeted Re-sequencing, Whole Genome Sequencing, Transcriptome (RNA-Seq), Whole Exome Sequencing, De Novo Sequencing, ChiP Sequencing, Methylation Sequencing, and Others), By Application (Diagnostics, Drug Discovery & Development, Biomarker Discovery, Agriculture & Animal Health Research, and Personalised Medicine) By End User (Academic Institutes & Research Centers, Hospital/Clinical Laboratories, Biotech/Pharmaceuticals Companies, and Others), and Country  

checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

Asia Pacific Next Generation Sequencing Market size was valued at US$ 570 million in 2022 and is poised to grow at a CAGR of 24.0%  from 2024-2030. Massively parallel sequencing (MPS) is another name for next-generation sequencing (NGS) . This word refers to a DNA sequencing method that has benefited biotech, forensic biology, medical diagnosis, biological systematics, and virology. NGS has evolved as a method for completing clinical research, basic science, and applied science. In comparison to the earlier Sanger sequencing method, next-generation sequencing allows a full human genome to be sequenced in a fraction of the time.  With the help of next-generation sequencing (NGS), personalized oncology care has advanced significantly. The sequencing of malignant DNA is now possible quickly and affordably, revolutionizing the study of cancer treatments. The industry is anticipated to be significantly impacted by advancements in oncology and personalized medicine. Using NGS in a clinical environment opens up a number of exciting possibilities. As a result, each of these has an important influence on market expansion.  

Asia Pacific Next Generation Sequencing Market Dynamics

Divers: Platforms for next-generation sequencing (NGS) have progressed, The cost of genomic sequencing is decreasing, Regulatory and reimbursement scenarios for NGS-based diagnostic assays are improving. Restraints: Budget limits for end users in developing countries.

Asia Pacific Next Generation Sequencing Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2022

US$ 570 million

By Type

 

  • Products
    • Instruments & Software
    • Consumables (Reagents & kits)
  • Services
    • Sequencing Services
    • Data Analysis Services

By Technology

  • Whole Targeted Re-sequencing
  • Whole Genome Sequencing
  • Transcriptome (RNA-Seq)
  • Whole Exome Sequencing
  • De Novo Sequencing
  • ChiP Sequencing
  • Methylation Sequencing
  • Others

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Biomarker Discovery
  • Agriculture & Animal Health Research
  • Personalised Medicine

By End User

  • Academic Institutes & Research Centers
  • Hospital/Clinical Laboratories
  • Biotech/Pharmaceuticals Companies
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The asia pacific next generation sequencing market size was valued US$ 570 million in 2022

The report covers the countries market data: China, India, Japan, Australia & New Zealand

Agilent Technologies Inc. BGI (Beijing Genomics Institute) Biomatters Ltd. DNASTAR Inc. GATC Biotech Ag Genomatix Software GmbH Illumina Incorporated

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2. Asia Pacific Next Generation Sequencing (NGS) Market Introduction 
2.1. Asia Pacific Next Generation Sequencing (NGS) Market  - Taxonomy
2.2. Asia Pacific Next Generation Sequencing (NGS) Market  - Definitions
2.2.1.Type 
2.2.2.Technology
2.2.3.Application
2.2.4.End User
2.2.5.Country
3. Asia Pacific Next Generation Sequencing (NGS) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Asia Pacific Next Generation Sequencing (NGS) Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Asia Pacific Next Generation Sequencing (NGS) Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Product
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Service
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Asia Pacific Next Generation Sequencing (NGS) Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Whole Targeted Re-sequencing
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Whole Genome Sequencing
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Transcriptome (RNA-Seq)
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Whole Exome Sequencing
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. De Novo Sequencing
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. ChiP Sequencing
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Methylation Sequencing
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Others
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7. Asia Pacific Next Generation Sequencing (NGS) Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Diagnostics
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Drug Discovery & Development
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Biomarker Discovery
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Agriculture & Animal Health Research
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Personalised Medicine
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Asia Pacific Next Generation Sequencing (NGS) Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Academic Institutes & Research Centers
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Hospital/Clinical Laboratories
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Biotech/Pharmaceuticals Companies
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Asia Pacific Next Generation Sequencing (NGS) Market  By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. China
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. India
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Australia and New Zealand (ANZ)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Japan
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Rest of APAC
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.China Asia Pacific Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Product
10.1.2.Service
10.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Whole Targeted Re-sequencing
10.2.2.Whole Genome Sequencing
10.2.3.Transcriptome (RNA-Seq)
10.2.4.Whole Exome Sequencing
10.2.5.De Novo Sequencing
10.2.6.ChiP Sequencing
10.2.7.Methylation Sequencing
10.2.8.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diagnostics
10.3.2.Drug Discovery & Development
10.3.3.Biomarker Discovery
10.3.4.Agriculture & Animal Health Research
10.3.5.Personalised Medicine
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Academic Institutes & Research Centers
10.4.2.Hospital/Clinical Laboratories
10.4.3.Biotech/Pharmaceuticals Companies
10.4.4.Others
11.India Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Product
11.1.2.Service
11.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Whole Targeted Re-sequencing
11.2.2.Whole Genome Sequencing
11.2.3.Transcriptome (RNA-Seq)
11.2.4.Whole Exome Sequencing
11.2.5.De Novo Sequencing
11.2.6.ChiP Sequencing
11.2.7.Methylation Sequencing
11.2.8.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diagnostics
11.3.2.Drug Discovery & Development
11.3.3.Biomarker Discovery
11.3.4.Agriculture & Animal Health Research
11.3.5.Personalised Medicine
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Academic Institutes & Research Centers
11.4.2.Hospital/Clinical Laboratories
11.4.3.Biotech/Pharmaceuticals Companies
11.4.4.Others
12.Australia and New Zealand (ANZ) Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Product
12.1.2.Service
12.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Whole Targeted Re-sequencing
12.2.2.Whole Genome Sequencing
12.2.3.Transcriptome (RNA-Seq)
12.2.4.Whole Exome Sequencing
12.2.5.De Novo Sequencing
12.2.6.ChiP Sequencing
12.2.7.Methylation Sequencing
12.2.8.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diagnostics
12.3.2.Drug Discovery & Development
12.3.3.Biomarker Discovery
12.3.4.Agriculture & Animal Health Research
12.3.5.Personalised Medicine
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Academic Institutes & Research Centers
12.4.2.Hospital/Clinical Laboratories
12.4.3.Biotech/Pharmaceuticals Companies
12.4.4.Others
13.Japan Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Product
13.1.2.Service
13.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Whole Targeted Re-sequencing
13.2.2.Whole Genome Sequencing
13.2.3.Transcriptome (RNA-Seq)
13.2.4.Whole Exome Sequencing
13.2.5.De Novo Sequencing
13.2.6.ChiP Sequencing
13.2.7.Methylation Sequencing
13.2.8.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diagnostics
13.3.2.Drug Discovery & Development
13.3.3.Biomarker Discovery
13.3.4.Agriculture & Animal Health Research
13.3.5.Personalised Medicine
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Academic Institutes & Research Centers
13.4.2.Hospital/Clinical Laboratories
13.4.3.Biotech/Pharmaceuticals Companies
13.4.4.Others
14.Rest of APAC Next Generation Sequencing (NGS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Product
14.1.2.Service
14.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Whole Targeted Re-sequencing
14.2.2.Whole Genome Sequencing
14.2.3.Transcriptome (RNA-Seq)
14.2.4.Whole Exome Sequencing
14.2.5.De Novo Sequencing
14.2.6.ChiP Sequencing
14.2.7.Methylation Sequencing
14.2.8.Others
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Diagnostics
14.3.2.Drug Discovery & Development
14.3.3.Biomarker Discovery
14.3.4.Agriculture & Animal Health Research
14.3.5.Personalised Medicine
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Academic Institutes & Research Centers
14.4.2.Hospital/Clinical Laboratories
14.4.3.Biotech/Pharmaceuticals Companies
14.4.4.Others
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Agilent Technologies Inc.
15.2.2.BGI (Beijing Genomics Institute)
15.2.3.Biomatters Ltd.
15.2.4.DNASTAR Inc.
15.2.5.GATC Biotech Ag
15.2.6.Genomatix Software GmbH
15.2.7.Illumina Incorporated
15.2.8.Knome Inc.
15.2.9.Life Sciences (Roche)
15.2.10.Macrogen Inc.
15.2.11.Oxford Nanopore Technologies Ltd.
15.2.12.Pacific Biosciences
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Agilent Technologies Inc.
  • BGI (Beijing Genomics Institute)
  • Biomatters Ltd.
  • DNASTAR Inc.
  • GATC Biotech Ag
  • Genomatix Software GmbH
  • Illumina Incorporated
  • Knome Inc.
  • Life Sciences (Roche)
  • Macrogen Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences
  • Partek Inc.
  • Perkin Elmer Inc.
  • Qiagen N.V
  • Thermo Fischer Scientific

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market